Keyphrases
Anticoagulation
11%
Atrial Fibrillation
100%
Bleeding
11%
Bleeding Risk
22%
Clinical Outcomes
100%
Cumulative Deficit
11%
Deficit Model
11%
Direct Oral Anticoagulants
22%
Double Dummy
11%
Edoxaban
33%
Efficacy Endpoint
11%
Factor Xa
11%
Frailty
100%
Frailty Index
11%
Frailty Status
11%
Health Deficits
11%
Index-based
11%
Lack of Data
11%
Living with
22%
Low Dose Rate
11%
Low Risk
11%
Major Bleeding
22%
Myocardial Infarction
11%
Older People
11%
Once-daily Regimen
11%
Oral Anticoagulation
11%
Pre-frailty
22%
Randomized Controlled Trial
11%
Safety Endpoints
11%
Severe Frailty
44%
Specific Populations
11%
Standardized Index
11%
Stroke Risk
33%
Systemic Embolism
33%
Trial Registration
11%
Vulnerable Populations
11%
Warfarin
44%
Medicine and Dentistry
Anticoagulation
11%
Apoplexy
23%
Atrial Fibrillation
100%
Bleeding
5%
Direct Oral Anticoagulant
11%
Edoxaban
17%
Frailty
100%
Major Bleeding
11%
Myocardial Infarction
5%
Population Research
5%
Post-Hoc Analysis
5%
Prothrombinase
5%
Randomized Controlled Trial
5%
Vulnerable Population
5%
Warfarin
23%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Bleeding
17%
Blood Clotting Factor 10a
5%
Direct Oral Anticoagulant
11%
Edoxaban
17%
Frailty
100%
Heart Infarction
5%
Population Study
5%
Randomized Controlled Trial
5%
Warfarin
23%